Table 5.
Primary tumor cell lines used in this study.
| No. | Primary Tumor Cell Name | Tumor Type (Origin) | Passage |
|---|---|---|---|
| Carcinomas | |||
| 1 | INT | Basal cell carcinoma (peritoneal dissemination) | 8 |
| 2 | Jack | Prostate cancer (Prostate) | 14 |
| 3 | Gal | Squamous cell carcinoma (Nasal cavity) | 16 |
| 4 | YDP | Transitional cell carcinoma (Bladder) | 9 |
| 5 | HDC | Adenocarcinoma (Lung) | 8 |
| 6 | LuBi | Adenocarcinoma (Lung) | 20 |
| 7 | JDM | Adenocarcinoma (Lung) | 25 |
| 8 | FBC | Adenocarcinoma (Nasal cavity) | 20 |
| 9 | SNP | Mammary gland tumor (Malignant pleural effusion) | 91 |
| Sarcomas | |||
| 10 | SGR | Osteosarcoma (Tibia) | 17 |
| 11 | KLC | Chondrosarcoma (Nasal cavity) | 9 |
| 12 | DML | Liposarcoma (Subcutis) | 60 |
| 13 | YCC | Melanoma (Oral cavity) | 10 |
| 14 | ITP | Melanoma (Oral cavity) | 6 |
| 15 | HTR | Melanoma (Oral cavity) | 12 |